In the last trading session, 0.16 million shares of the ABVC BioPharma Inc (NASDAQ:ABVC) were traded, and its beta was 0.71. Most recently the company’s share price was $0.59, and it changed around $0.0 or -0.12% from the last close, which brings the market valuation of the company to $7.65M. ABVC currently trades at a discount to its 52-week high of $2.45, offering almost -315.25% off that amount. The share price’s 52-week low was $0.41, which indicates that the current value has risen by an impressive 30.51% since then. We note from ABVC BioPharma Inc’s average daily trading volume that its 10-day average is 0.16 million shares, with the 3-month average coming to 262.98K.

ABVC BioPharma Inc stock received a consensus recommendation rating of Hold, based on a mean score of 3.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 1 recommended ABVC as a Hold, whereas 0 deemed it a Buy, and 0 rated it as Underweight. ABVC BioPharma Inc is expected to report earnings per share of 0 for the current quarter.

ABVC BioPharma Inc (NASDAQ:ABVC) trade information

Instantly ABVC has showed a red trend with a performance of -0.12% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 0.6295 on recent trading dayincreased the stock’s daily price by 6.27%. The company’s shares are currently down -49.14% year-to-date, but still up 11.32% over the last five days. On the other hand, ABVC BioPharma Inc (NASDAQ:ABVC) is 11.32% up in the 30-day period. We can see from the shorts that 0.19 million shares have been sold at a short interest cover period of 0.7 day(s).

Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 12.78%.

ABVC Dividends

ABVC BioPharma Inc’s next quarterly earnings report is expected to be released in February.

ABVC BioPharma Inc (NASDAQ:ABVC)’s Major holders

Upon looking at major shareholders, it appears that insiders hold 22.93% of ABVC BioPharma Inc shares, and 3.01% of them are in the hands of institutional investors. The stock currently has a share float of 3.91%.